Mesoblast Ltd Files 6-K Report
Ticker: MEOBF · Form: 6-K · Filed: Sep 4, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Sep 4, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, sec, regulatory-update
Related Tickers: MESO
TL;DR
MESO filed a 6-K on Sept 4th, check for updates.
AI Summary
On September 4, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a press release announced on the Australian Securities Exchange. The filing is for the month of September 2025 and includes information about the company's operations and reporting status.
Why It Matters
This filing indicates Mesoblast Limited is providing updated information to the SEC, which could contain material developments relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically provides updates or announcements, not a direct financial event like an earnings report or acquisition.
Key Players & Entities
- MESOBLAST LTD (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- September 4, 2025 (date) — Filing Date
- Australian Securities Exchange (company) — Exchange where press release was announced
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that provides information which the company may be required to make public in its home country, file with a stock exchange, or distribute to its security holders.
When was this Form 6-K filed?
This Form 6-K was filed on September 4, 2025.
What is the primary document attached to this 6-K filing?
The primary document attached is a new release announcement filed with the Australian Securities Exchange, incorporated as Exhibit 99.1.
What is Mesoblast Limited's jurisdiction of incorporation?
Mesoblast Limited is incorporated in Australia.
Who is the CEO of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Filing Stats: 260 words · 1 min read · ~1 pages · Grade level 15.3 · Accepted 2025-09-03 20:58:14
Filing Documents
- form6-kxpressreleasecoverf.htm (6-K) — 17KB
- exhbit991optiontoissueus.htm (EX-99.1) — 10KB
- exhbit992optiontoissueus.htm (EX-99.2) — 9KB
- exhbit991optiontoissueus001.jpg (GRAPHIC) — 261KB
- exhbit991optiontoissueus002.jpg (GRAPHIC) — 278KB
- exhbit991optiontoissueus003.jpg (GRAPHIC) — 47KB
- exhbit992optiontoissueus001.jpg (GRAPHIC) — 68KB
- exhbit992optiontoissueus002.jpg (GRAPHIC) — 98KB
- exhbit992optiontoissueus003.jpg (GRAPHIC) — 113KB
- exhbit992optiontoissueus004.jpg (GRAPHIC) — 151KB
- exhbit992optiontoissueus005.jpg (GRAPHIC) — 131KB
- 0001345099-25-000070.txt ( ) — 1614KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated September 4, 2025 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated September 4, 2025. 99.2 Appendix 3B of Mesoblast Ltd, dated September 4, 2025.